The Telehealth Boom Continues

New McKinsey analysis suggests that telehealth will maintain most of its pandemic-driven usage gains, which stabilized at 38X its pre-COVID baseline and 17% of all outpatient/office visit claims.

McKinsey’s findings highlight three primary driving factors:

Adoption

  • 40% of surveyed consumers believe they will continue to use telehealth, up from 11% before COVID-19
  • 84% of physicians are now offering virtual visits, while 57% wish to continue

Regulation

  • CMS made telehealth coverage for a number of CPT codes permanent in the 2021 physician fee schedule

Investment

  • Total digital health VC funding in 1H 2021 reached $14.7B, eclipsing 2020’s total ($14.6B)
  • Investment surge pressuring companies to innovate and find viable models
  • Top 60 digital health players had combined revenue of $5.5B in 2020, vs. $3B in 2019

The Takeaway

It may have been reasonable to expect telehealth usage to decline given the unique circumstances behind its massive growth. However, the combination of patient, clinician, and business momentum suggests that most of telehealth’s share gains could persist.

The Health App Scorecard

A recent study in Nature provided a new scorecard approach for evaluating which digital health applications actually produce meaningful clinical results, using a sample of oncology apps to demonstrate the need for standardized evaluation criteria.

The Problem – Low entry barriers have created a confusing digital health landscape, with the growth of apps outpacing digital health stakeholders’ ability to validate their quality.

The Solution – The study evaluated 22 popular oncology mobile apps using a digital health scorecard with 5 evaluation criteria (technical, clinical, usability, end user requirements, cost).

The Results – Although usability was adequate, the oncology apps carried significant technical limitations, were of limited clinical value, and “generally did not do what end users wanted.”

Across all 22 apps, the average score (100% max) for each criteria was:

  • Cost – 100% (all apps were free)
  • Usability – 56.7%
  • Technical – 37.3%
  • End-User Requirements – 37.2%
  • Clinical – 15.9%

The Takeaway

Healthcare apps are here to stay, but the shortcomings of highly downloaded oncology apps highlights the need for standardized frameworks like this scorecard to evaluate their clinical appropriateness. We’ll also need far more healthcare apps that satisfy these criteria.

Get the top digital health stories right in your inbox

You might also like..

Select All

You're signed up!

It's great to have you as a reader. Check your inbox for a welcome email.

-- The Digital Health Wire team

You're all set!